Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2026 09:41 ET | Source: Research and Markets

KLK2-Targeted Immunotherapies Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase and Profile of Targeted Immunotherapies by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of KLK2-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
May 14, 2026 09:40 ET | Source: Research and Markets

Glypican-3 (GPC3) Targeted Therapy Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase and Profile of Targeted Immunotherapies by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Glypican-3 (GPC3) Targeted Therapy: a Competitor Analysis" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence...
May 14, 2026 09:39 ET | Source: Research and Markets

PD-L1 X 4-1BB (CD137) Bispecific Antibodies Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase and Profile of Bispecific Antibodies by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of PD-L1 x 4-1BB (CD137) Bispecific Antibodies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence...
May 14, 2026 09:38 ET | Source: Research and Markets

PSMA-Targeted Therapy & Radiodiagnostics Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase and Profile of Targeted Therapies or Radio-diagnostics by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Competitor Analysis: PSMA-Targeted Therapy & Radiodiagnostics" report has been added to ResearchAndMarkets.com's offering.This competitive...
May 14, 2026 09:35 ET | Source: Research and Markets

Folate Receptor alpha (FRa) Targeted Therapy Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase and Profile of Targeted Immunotherapies by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Folate Receptor alpha (FRa) Targeted Therapy: a Competitor Analysis" report has been added to ResearchAndMarkets.com's offering.This competitive...
May 07, 2026 09:08 ET | Source: Research and Markets

Bi-Specific MAbS Market Research Report 2026: $21.83 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, May 07, 2026 (GLOBE NEWSWIRE) -- The "Bi-Specific MAbS Market Report 2026" has been added to ResearchAndMarkets.com's offering. The bi-specific monoclonal antibodies (mAbs) market is...
April 21, 2026 04:49 ET | Source: Research and Markets

Bispecific Antibody Drug Conjugates Market Landscape Report 2026: A $2 Billion Opportunity by 2030 with the 1st Approved BsADC by 2028 - Clinical Trials, Regulatory Approvals, Development Platforms

Dublin, April 21, 2026 (GLOBE NEWSWIRE) -- The "Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals, Development Platforms & Market Opportunity Insight 2026" report has...
April 21, 2026 04:34 ET | Source: Research and Markets

Bispecific Antibody Market Landscape Report 2026: A Potential $60 Opportunity by 2031 - Insight on More than 550 Clinical Trials - Antibody Dosage, Patent, Price, Sales & Outlook

Dublin, April 21, 2026 (GLOBE NEWSWIRE) -- The "Bispecific Antibody Market Opportunity, Antibody Dosage, Patent, Price, Sales & Clinical Trials Outlook 2031" report has been added to ...
April 13, 2026 05:47 ET | Source: Research and Markets

Bispecific Antibodies Market Research and Competitive Landscape Report 2026: Comprehensive Insights Into Over 180 Companies and 250 Drugs

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Bispecific Antibodies - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report offers comprehensive...
April 10, 2026 08:15 ET | Source: BCC Research LLC

Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate

Report provides in-depth insights into technological developments, pipeline trends, and global opportunities shaping the future of bispecific antibodies.